ST ELIZABETH HEALTHCARE
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $5.8M
- Transactions
- 934
- Companies
- 40
- Average per transaction
- $6,252
Who reported the payments
| Merck | $1,263,555 |
| Pfizer | $781,983 |
| Medtronic | $604,434 |
| Astrazeneca UK Limited | $363,737 |
| Amgen | $293,983 |
| E.r. Squibb & Sons, L.L.C. | $286,616 |
| AstraZeneca | $276,781 |
| Janssen Research & Development, LLC | $188,388 |
| Cleerly, Inc. | $175,892 |
| Edwards Lifesciences | $145,309 |
| Johnson & Johnson | $143,821 |
| Insulet Corporation | $118,600 |
| Instylla, Inc. | $101,252 |
| Genentech, Inc. | $100,171 |
| Eli Lilly | $97,682 |
| Genmab U.S., Inc. | $78,687 |
| Boehringer Ingelheim International GmbH | $69,835 |
| Linvatec Corporation | $60,469 |
| Stryker | $55,735 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | $48,796 |
| Abbott | $46,100 |
| Penumbra, Inc. | $46,015 |
| Inari Medical, Inc. | $43,066 |
| AbbVie | $40,998 |
| Daiichi Sankyo Inc. | $40,349 |
| Novocure GmbH | $38,315 |
| Novo Nordisk AS | $36,005 |
| Novartis | $27,537 |
| Novocure Inc. | $25,700 |
| Boston Scientific | $25,435 |
| Ascendis Pharma Endocrinology Inc | $24,462 |
| Cathworks, Inc. | $22,200 |
| Intuitive Surgical | $20,000 |
| Magenta Medical Inc | $18,700 |
| Hologic Inc | $14,578 |
| EKOS Corporation | $11,088 |
| Medical Device Business Services, Inc. | $10,500 |
| Livanova USA, Inc. | $8,840 |
| Incyte Corporation | $7,710 |
| Corcept Therapeutics | $7,213 |